Category Archives: Prognosis

EUH Hunt Conference: What is the prognosis for adenocarcinoma of the lung?

The Bottom Line: There is an overall survival rate of less than 5 years. Stage I: 68-92% Stage II: 53-60% Stage III: 13-36% Stage IV: 0-10% Reference: DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995 – . Record No. 114774, Non-small … Continue reading

Posted in EUH, Prognosis, Teaching pearls

EUH Hunt Conference: What is the prognosis for patients with HIV-negative PCNSL?

The Bottom Line: Patients diagnosed with primary central nervous system lymphoma (PCNSL) who are HIV-negative have a higher prognosis compared to those with PCNSL who are HIV-positive. While the median survival range is from 10-20 months for HIV-positive PCNSL patients, there … Continue reading

Posted in EUH, Prognosis

EUH Hunt Conference: Review of Meigs’ Syndrome

Bottom Line: Meigs’ syndrome is also known as Meigs syndrome or Demons-Meigs syndrome. It is characterized by a triad of ascites, pleural effusion, and benign ovarian fibroma, which is a rare triad. “Meigs syndrome…is a diagnosis of exclusion only after ovarian carcinoma … Continue reading

Posted in Background question, EUH, Prognosis, Therapy | Tagged ,

Kokko Conference: Does TTP (thrombotic thrombocytopenic purpura) result in ARDS (acute respiratory distress syndrome)?

The Bottom Line: Life-threatening ARDS can be associated with TTP. Early recognition of ARDS associated with TTP and timely EP is critical to a favorable outcome. Summary: Experience suggests that ARDS may occur as a clinical feature of either de novo … Continue reading

Posted in Grady, Prognosis

EUH Hunt Conference: What is the treatment for insulinomas?

The Bottom Line:  Diet: small frequent meals throughout the day and in them idle of the night to prevent hypoglycemia (DynaMed Plus, 2017). Medications: Diazoxide is administered to suppress insulin release. For incurable islet cell carcinomas, steptozocin is the best … Continue reading

Posted in EUH, Prognosis, Therapy

EUH Hunt Conference: What are the treatments and outcomes for anti-GABA(B) associated encephalitis with small-cell lung cancer?

The Bottom Line: GABA(B) encephalitis shows typical clinical patterns of afebrile limbic encephalitis and intractable seizures, and is associated with small-cell lung cancer. Immunomodulation and cancer chemotherapy often improve the neurological deficits (Kim et al 2014). Patients with small-cell lung … Continue reading

Posted in EUH, Prognosis, Therapy

EUH Resident Report: What is antisynthetase syndrome?

The Bottom Line: Antisynthetase syndrome is a clinical condition characterized by arthritis, mechanic’s hand sign, interstitial lung disease (ILD), fever, Raynaud’s phenomenon, and myositis. ILD is the most severe manifestation, occurring in approximately 80% of antisynthetase syndrome patients, and is … Continue reading

Posted in Background question, Diagnosis, EUH, Prognosis